annual CFO:
-$142.06M+$18.29M(+11.40%)Summary
- As of today (July 1, 2025), CNTA annual cash flow from operations is -$142.06 million, with the most recent change of +$18.29 million (+11.40%) on December 31, 2024.
- CNTA annual CFO is now -2338.71% below its all-time high of -$5.83 million, reached on December 31, 2019.
Performance
CNTA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$57.25M-$14.45M(-33.75%)Summary
- As of today (July 1, 2025), CNTA quarterly cash flow from operations is -$57.25 million, with the most recent change of -$14.45 million (-33.75%) on March 31, 2025.
- Over the past year, CNTA quarterly CFO has dropped by -$19.96 million (-53.53%).
- CNTA quarterly CFO is now -167.64% below its all-time high of -$21.39 million, reached on September 30, 2024.
Performance
CNTA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$162.01M-$19.96M(-14.05%)Summary
- As of today (July 1, 2025), CNTA TTM cash flow from operations is -$162.01 million, with the most recent change of -$19.96 million (-14.05%) on March 31, 2025.
- Over the past year, CNTA TTM CFO has dropped by -$12.22 million (-8.16%).
- CNTA TTM CFO is now -223.92% below its all-time high of -$50.02 million, reached on March 31, 2022.
Performance
CNTA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CNTA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | -53.5% | -8.2% |
| 3 y3 years | - | -14.4% | -223.9% |
| 5 y5 years | -2338.7% | - | - |
CNTA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.2% | -167.6% | +4.4% | -47.4% | +19.2% |
| 5 y | 5-year | -1236.4% | +29.2% | -167.6% | +4.4% | -223.9% | +19.2% |
| alltime | all time | -2338.7% | +29.2% | -167.6% | +4.4% | -223.9% | +19.2% |
CNTA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$57.25M(+33.8%) | -$162.01M(+14.1%) |
| Dec 2024 | -$142.06M(-11.4%) | -$42.80M(+100.1%) | -$142.06M(+9.0%) |
| Sep 2024 | - | -$21.39M(-47.3%) | -$130.31M(-10.9%) |
| Jun 2024 | - | -$40.58M(+8.8%) | -$146.31M(-2.3%) |
| Mar 2024 | - | -$37.29M(+20.1%) | -$149.79M(-6.6%) |
| Dec 2023 | -$160.34M | -$31.05M(-17.0%) | -$160.34M(-11.3%) |
| Sep 2023 | - | -$37.39M(-15.1%) | -$180.86M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$44.06M(-7.9%) | -$182.55M(-8.0%) |
| Mar 2023 | - | -$47.84M(-7.2%) | -$198.37M(-1.1%) |
| Dec 2022 | -$200.55M(+1786.6%) | -$51.56M(+31.9%) | -$200.55M(+34.6%) |
| Sep 2022 | - | -$39.09M(-34.7%) | -$148.98M(+35.6%) |
| Jun 2022 | - | -$59.88M(+19.7%) | -$109.89M(+119.7%) |
| Mar 2022 | - | -$50.02M | -$50.02M |
| Dec 2020 | -$10.63M(+82.5%) | - | - |
| Dec 2019 | -$5.83M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual CFO year-on-year change?
- What is Centessa Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly CFO year-on-year change?
- What is Centessa Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM CFO year-on-year change?
What is Centessa Pharmaceuticals annual cash flow from operations?
The current annual CFO of CNTA is -$142.06M
What is the all time high annual CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual cash flow from operations is -$5.83M
What is Centessa Pharmaceuticals annual CFO year-on-year change?
Over the past year, CNTA annual cash flow from operations has changed by +$18.29M (+11.40%)
What is Centessa Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CNTA is -$57.25M
What is the all time high quarterly CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly cash flow from operations is -$21.39M
What is Centessa Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CNTA quarterly cash flow from operations has changed by -$19.96M (-53.53%)
What is Centessa Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CNTA is -$162.01M
What is the all time high TTM CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM cash flow from operations is -$50.02M
What is Centessa Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CNTA TTM cash flow from operations has changed by -$12.22M (-8.16%)